NPI: 1548359730 · LAWNDALE, CA 90260 · Community Health Clinic/Center · NPI assigned 10/12/2006
Authorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | PAHL, LINDA (CFO) |
| NPI Enumeration Date | 10/12/2006 |
Other providers sharing the same authorized official: PAHL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 32,585 | $1.36M |
| 2019 | 17,266 | $745K |
| 2020 | 17,056 | $709K |
| 2021 | 21,229 | $920K |
| 2022 | 16,455 | $783K |
| 2023 | 20,172 | $1.03M |
| 2024 | 15,037 | $738K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6,960 | 6,550 | $846K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,982 | 3,804 | $792K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 9,286 | 8,944 | $764K |
| J3490 | Unclassified drugs | 18,318 | 15,951 | $681K |
| S4993 | Contraceptive pills for birth control | 5,086 | 5,069 | $576K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,694 | 1,657 | $526K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,954 | 1,931 | $362K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 344 | 343 | $308K |
| 87806 | 8,870 | 6,723 | $219K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6,443 | 6,314 | $214K |
| 99401 | 6,987 | 6,809 | $133K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 306 | 306 | $119K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6,493 | 6,357 | $104K |
| 11981 | 335 | 333 | $78K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,874 | 1,734 | $73K |
| A4267 | Contraceptive supply, condom, male, each | 10,371 | 10,190 | $67K |
| 99201 | 545 | 524 | $59K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 197 | 197 | $59K |
| 81025 | 14,812 | 14,349 | $59K | |
| 58300 | 390 | 187 | $35K | |
| S5000 | Prescription drug, generic | 4,995 | 4,794 | $33K |
| 11976 | 477 | 243 | $29K | |
| 83986 | 8,192 | 6,650 | $22K | |
| 99000 | 6,060 | 6,031 | $21K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 241 | 240 | $19K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 4,901 | 4,753 | $18K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 1,403 | 1,403 | $18K |
| 86703 | 1,325 | 1,070 | $13K | |
| 99402 | 309 | 307 | $10K | |
| 58301 | 231 | 117 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 380 | 380 | $6K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 1,274 | 1,254 | $5K |
| 81002 | 2,119 | 2,072 | $4K | |
| 86592 | 1,233 | 1,228 | $4K | |
| 82120 | 562 | 547 | $2K | |
| 87210 | 551 | 535 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 300 | 266 | $2K |